Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,854
datasets available to search
ShareScore release 0.9.0
Dataset results
2,854 results for “Hepatocellular carcinoma”
Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Participants With Advanced Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07175441. IPD Sharing: NO. Countries: 1. Publications: 0.
Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation
ClinicalTrials.gov study NCT01340105. IPD Sharing: NO. Countries: 1. Publications: 0.
Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells
ClinicalTrials.gov study NCT05628545. IPD Sharing: NO. Countries: 1. Publications: 0.
Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)
ClinicalTrials.gov study NCT00963612. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma
ClinicalTrials.gov study NCT02415036. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02724436. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01078311. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Durvalumab Plus Lenvatinib as First-line Treatment for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05312216. IPD Sharing: NO. Countries: 1. Publications: 0.
To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization
ClinicalTrials.gov study NCT06478719. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lparomlimab and Tuvonralimab Injection in Combination With TACE and Lenvatinib in the Treatment of Second-Line Therapy for Unresectable Intermediate-to-Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07099274. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT06530251. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06241326. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05925413. IPD Sharing: NO. Countries: 1. Publications: 0.
Hepatocellular Carcinoma Identification Using Delta-HLD
ClinicalTrials.gov study NCT07148310. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study Evaluating the Efficacy and Safety of ZG005 in Combination With Donafenib or Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06233994. IPD Sharing: NO. Countries: 1. Publications: 0.
The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03652467. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GPC3-CAR-T Cells for the Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04506983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Recurrence Patterns and Cost-Effectiveness of Surgical Approaches in Early-Stage Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06776185. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03908840. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Apatinib Combined With TACE in Advance Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03398122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.